UPL

UPL vs Peers

₹499.20-2.03%
Market cap
₹42,141 crore
P/E
21.6
P/B
1.21
ROE
5.5%
Dividend yield
1.20%

UPL ranks 1st by market capitalisation among 14 Pesticides & Agrochemicals companies tracked by ATS. Its largest peers are PI Industries, Sumitomo Chemical India and Bayer Cropscience. Its P/E of 21.6 compares with a peer median of 21.9.

UPL vs Pesticides & Agrochemicals peers

Sorted by market capitalisation.

UPL and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
UPL499.20-2.03%42,14121.61.215.5%+22.0%
PI Industries2,204.70-2.01%33,44728.72.9812.4%+12.5%
Sumitomo Chemical India422.45+1.05%21,08636.46.2217.3%+12.5%
Bayer Cropscience3,489.00-1.26%15,68021.45.2923.7%+12.5%
Sharda Cropchem743.00+0.17%6,70310.72.1424.2%+12.5%
Dhanuka Agritech891.35-2.00%4,01815.02.3918.6%+12.5%
Rallis India200.00-0.15%3,88918.21.909.3%+12.5%
Bhagiradha Chemicals & Industries236.35-1.48%3,065111.44.392.6%+12.5%
GSP Crop Science482.80+1.29%2,24622.33.2016.4%+12.5%
Astec LifeSciences742.35+5.34%1,65422.54.23-25.9%+12.5%
Bharat Rasayan989.00-0.93%1,64411.51.2912.1%+12.5%

Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.

UPL peer comparison — frequently asked questions

Who are UPL's competitors?

UPL's listed peers in Pesticides & Agrochemicals include PI Industries, Sumitomo Chemical India, Bayer Cropscience, Sharda Cropchem, Dhanuka Agritech and Rallis India, ranked here by market capitalisation.

How does UPL's P/E compare with its peers?

UPL trades at a P/E of 21.6, against a median of 21.9 across the 10 Pesticides & Agrochemicals peers shown.

Which is the largest company among UPL's peers?

By market capitalisation, the largest company in the group is PI Industries at ₹33,447 crore, against ₹42,141 crore for UPL.

Same Data For Peers

Trade UPL With ATS

Track UPL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.